Selective increases in cytokine expression in the rat brain in response to striatal injection of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and interleukin-1

Molecular Brain Research

Volumn 93, Issue 2, 2001, Pages 180-189

  Allan, Stuart M ^a   Harrison, David C ^b   Read, Simon ^b   Collins, Barry ^a   Parsons, Andrew A ^b   Philpott, Karen ^b   Rothwell, Nancy J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cell death; Cytokines; Excitotoxicity; S AMPA

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CYTOKINE; EXCITOTOXIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; INJECTION SITE; MALE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TISSUE DISTRIBUTION; TISSUE LEVEL;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; APOPTOSIS; CEREBRAL CORTEX; CORPUS STRIATUM; CYTOKINES; DNA, COMPLEMENTARY; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKINS; MALE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035975602     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(01)00211-X     Document Type: Article

References (38)

1. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain
2. Cortical cell death induced by interleukin-1 is mediated via actions in the hypothalamus of the rat
3. Cortical death caused by striatal administration of AMPA and interleukin-1 is mediated by activation of cortical NMDA receptors
4. Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system
5. Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain
6. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
7. Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid
8. Inhibition of kainic acid induced expression of interleukin-1beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists
9. Expression of interleukin-1 genes and interleukin-1 receptors in the mouse brain after hippocampal injury
10. Basal and IL-1β-stimulated cytokine and neuropeptide mRNA expression in brain regions of young and old Long-Evans rats
11. The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischemia-caspase-3 as a case study
12. Temporal modulation of cytokine expression following focal cerebral ischemia in mice
13. Cytokines and the nervous system. I: Expression and recognition
14. Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia
15. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat
16. Quantitative changes in interleukin proteins following focal stroke in the rat
17. Tumor necrosis factor-a attenuates N-methyl-D-aspartate-mediated neurotoxicity in neonatal rat hippocampus
18. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat
19. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat
20. Endogenous interleukin-1 receptor antagonist is neuroprotective
21. Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: Correlation with the progression of cell death
22. Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions
23. Rat interleukin-6: Expression in recombinant Escherichia coli, purification and development of a novel ELISA
24. Cytokines - Killers in the brain?
25. Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid
26. Dual role of tumor necrosis factor alpha in brain injury
27. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat
28. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat
29. Localization of TNFα and IL-1α immunoreactivities in striatal neurons after surgical injury to the hippocampus
30. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
31. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons
32. Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures
33. Cytokine signals propagate through the brain
34. Dynamic regulation of the proinflammatory cytokine, interleukin-1β: Molecular biology for non-molecular biologists
35. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats
36. Gene expression of IL-10 in relationship to TNF-α, IL-1β and IL-2 in the rat brain following middle cerebral artery occlusion
37. Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives